Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Ciclesonide on Small Airways in Patients With Stable Asthma (18 to 60 y) (BY9010/M1-131)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Main Inclusion Criteria:~* Written informed consent~* History of bronchial asthma~* FEV1 more than or equal to 60% of predicted~* Stable asthma~* Patients who are in good health with the exception of asthma~Main Exclusion Criteria:~* Concomitant severe diseases, diseases expected to interfere with the outcome of the study, or diseases which are contraindications for the use of ICS~* COPD (i.e. chronic bronchitis or emphysema) and/or other relevant lung diseases causing alternating impairment in lung function~* Use of ICS 4 weeks before entry into the baseline period~* Pregnancy~* Intention to become pregnant during the course of the study~* Breast feeding~* Lack of safe contraception~* Use of other drugs not allowed~* Current smokers and ex-smokers with more than or equal to 10 pack-years

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).